Male vitamin D status and male factor infertility

Fertil Steril. 2021 Oct;116(4):973-979. doi: 10.1016/j.fertnstert.2021.06.035. Epub 2021 Jul 18.

Abstract

Objective: To determine the association between vitamin D levels in the male partner and fertility outcomes in couples with mild male factor infertility.

Design: Secondary analysis of a randomized, controlled trial.

Setting: Nine fertility centers in the United States.

Patient(s): Men (n = 154) with sperm concentration between 5 and 15 million/mL, motility ≤40%, or normal morphology ≤4% were eligible. Female partners were ovulatory, ≤40 years old, and had documented tubal patency.

Intervention(s): Men provided semen and blood at baseline for semen analysis and 25-hydroxyvitamin D (25(OH)D) levels. They were randomly assigned to receive a vitamin formulation including vitamin D 2,000 IU daily or placebo for up to 6 months. Couples attempted to conceive naturally during the first 3 months and with clomiphene citrate with intrauterine insemination of the female partner in months 4 through 6.

Main outcome measure(s): Primary: sperm concentration, motility, morphology, and DNA fragmentation at baseline. Secondary: cumulative pregnancy, miscarriage, and live birth rates.

Result(s): Semen parameters and sperm DNA fragmentation were not statistically significantly different between men with vitamin D deficiency and men with 25(OH)D levels ≥20 ng/mL. In addition, clinical pregnancy and live birth rates were similar. Male 25(OH)D level <20 ng/mL was associated with a higher rate of pregnancy loss (adjusted odds ratio 9.0; 95% confidence interval 1.3 to 61.3).

Conclusion(s): Vitamin D deficiency in the male partner did not significantly impact semen parameters or treatment outcomes. Further study is warranted to better characterize the rate of miscarriage in couples with male vitamin D deficiency.

Keywords: 25-Hydroxyvitamin D; male factor infertility; vitamin D.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Abortion, Spontaneous / etiology
  • Adult
  • Biomarkers / blood
  • Clomiphene / adverse effects
  • Clomiphene / therapeutic use*
  • Dietary Supplements
  • Double-Blind Method
  • Female
  • Fertility Agents, Female / adverse effects
  • Fertility Agents, Female / therapeutic use*
  • Fertility* / drug effects
  • Humans
  • Infertility, Male / blood
  • Infertility, Male / diagnosis
  • Infertility, Male / physiopathology
  • Infertility, Male / therapy*
  • Insemination, Artificial, Homologous* / adverse effects
  • Live Birth
  • Male
  • Pregnancy
  • Pregnancy Rate
  • Prospective Studies
  • Risk Factors
  • Semen / metabolism
  • Semen Analysis
  • Time Factors
  • Treatment Outcome
  • United States
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood
  • Vitamin D / therapeutic use
  • Vitamin D Deficiency / blood*
  • Vitamin D Deficiency / diagnosis
  • Vitamin D Deficiency / drug therapy

Substances

  • Biomarkers
  • Fertility Agents, Female
  • Vitamin D
  • Clomiphene
  • 25-hydroxyvitamin D